| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 36 | 2024 | 2516 | 3.160 |
Why?
|
| Heart Transplantation | 20 | 2023 | 908 | 3.130 |
Why?
|
| Tissue and Organ Procurement | 4 | 2023 | 233 | 1.740 |
Why?
|
| Heart-Assist Devices | 17 | 2024 | 1171 | 1.500 |
Why?
|
| Cardiovascular System | 4 | 2023 | 145 | 1.390 |
Why?
|
| Graft Rejection | 6 | 2017 | 834 | 1.350 |
Why?
|
| Complement C4b | 2 | 2017 | 7 | 0.960 |
Why?
|
| Myocardium | 7 | 2018 | 1313 | 0.930 |
Why?
|
| Cardiology | 7 | 2022 | 530 | 0.850 |
Why?
|
| Telemedicine | 2 | 2022 | 471 | 0.660 |
Why?
|
| Legislation, Medical | 1 | 2018 | 14 | 0.650 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2015 | 69 | 0.610 |
Why?
|
| Advance Care Planning | 3 | 2023 | 86 | 0.590 |
Why?
|
| Decision Making | 3 | 2023 | 1287 | 0.560 |
Why?
|
| Toxoplasmosis | 1 | 2015 | 28 | 0.530 |
Why?
|
| Serum Sickness | 1 | 2015 | 5 | 0.520 |
Why?
|
| Informed Consent | 1 | 2018 | 419 | 0.510 |
Why?
|
| Forecasting | 1 | 2017 | 694 | 0.490 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 71 | 0.480 |
Why?
|
| Antilymphocyte Serum | 1 | 2015 | 228 | 0.480 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 160 | 0.460 |
Why?
|
| Advance Directives | 3 | 2018 | 88 | 0.460 |
Why?
|
| Posture | 1 | 2014 | 215 | 0.460 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2015 | 244 | 0.450 |
Why?
|
| Sinus of Valsalva | 2 | 2003 | 53 | 0.440 |
Why?
|
| Patient Positioning | 1 | 2014 | 195 | 0.430 |
Why?
|
| Catheterization, Peripheral | 1 | 2014 | 158 | 0.430 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7548 | 0.430 |
Why?
|
| Cardiac Rehabilitation | 2 | 2022 | 23 | 0.420 |
Why?
|
| Aortic Rupture | 2 | 2003 | 113 | 0.420 |
Why?
|
| Tissue Donors | 4 | 2023 | 769 | 0.390 |
Why?
|
| Ventricular Function, Left | 6 | 2022 | 603 | 0.390 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2017 | 66 | 0.390 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 1021 | 0.380 |
Why?
|
| Quality of Life | 3 | 2022 | 4532 | 0.380 |
Why?
|
| Echocardiography | 5 | 2018 | 1182 | 0.380 |
Why?
|
| Aortic Aneurysm | 2 | 2003 | 230 | 0.370 |
Why?
|
| Cardiomyopathies | 5 | 2021 | 610 | 0.370 |
Why?
|
| Palliative Care | 2 | 2020 | 2037 | 0.360 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2016 | 167 | 0.360 |
Why?
|
| Heart-Lung Transplantation | 2 | 2022 | 24 | 0.360 |
Why?
|
| Humans | 70 | 2024 | 261506 | 0.350 |
Why?
|
| Kidney Transplantation | 4 | 2023 | 755 | 0.340 |
Why?
|
| Coronary Care Units | 1 | 2007 | 46 | 0.310 |
Why?
|
| Echocardiography, Doppler | 3 | 2016 | 180 | 0.290 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 2195 | 0.290 |
Why?
|
| United States | 15 | 2023 | 15433 | 0.270 |
Why?
|
| Allografts | 2 | 2018 | 650 | 0.270 |
Why?
|
| Waiting Lists | 2 | 2017 | 263 | 0.270 |
Why?
|
| Subclavian Artery | 2 | 2015 | 80 | 0.250 |
Why?
|
| Antibodies | 1 | 2008 | 838 | 0.250 |
Why?
|
| Middle Aged | 29 | 2020 | 86204 | 0.240 |
Why?
|
| Hospitals, General | 1 | 2003 | 27 | 0.230 |
Why?
|
| Registries | 4 | 2023 | 2170 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2016 | 5542 | 0.230 |
Why?
|
| Male | 37 | 2023 | 123000 | 0.230 |
Why?
|
| Brain Death | 1 | 2023 | 53 | 0.230 |
Why?
|
| Stroke Volume | 5 | 2022 | 577 | 0.230 |
Why?
|
| Abortion, Legal | 1 | 2023 | 10 | 0.230 |
Why?
|
| American Heart Association | 5 | 2022 | 310 | 0.230 |
Why?
|
| Telerehabilitation | 1 | 2022 | 4 | 0.230 |
Why?
|
| Physician-Patient Relations | 2 | 2020 | 792 | 0.220 |
Why?
|
| Balloon Occlusion | 1 | 2003 | 49 | 0.220 |
Why?
|
| Cardiac Catheterization | 3 | 2017 | 687 | 0.220 |
Why?
|
| Dexamethasone | 1 | 2007 | 1450 | 0.220 |
Why?
|
| Hospitalization | 3 | 2021 | 2083 | 0.220 |
Why?
|
| Hemodynamics | 4 | 2017 | 935 | 0.210 |
Why?
|
| Peptide Fragments | 1 | 2008 | 1271 | 0.210 |
Why?
|
| Hospice Care | 1 | 2023 | 156 | 0.210 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2022 | 581 | 0.210 |
Why?
|
| Nephritis, Interstitial | 1 | 2023 | 76 | 0.210 |
Why?
|
| BK Virus | 1 | 2023 | 123 | 0.200 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 139 | 0.200 |
Why?
|
| Research Report | 4 | 2022 | 144 | 0.190 |
Why?
|
| Hospital Mortality | 3 | 2021 | 1274 | 0.190 |
Why?
|
| Biopsy | 3 | 2018 | 3443 | 0.190 |
Why?
|
| Graft Survival | 1 | 2023 | 1062 | 0.180 |
Why?
|
| Medical Futility | 1 | 2020 | 54 | 0.180 |
Why?
|
| Rivaroxaban | 1 | 2020 | 59 | 0.180 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 70 | 0.180 |
Why?
|
| Prealbumin | 2 | 2016 | 37 | 0.170 |
Why?
|
| Health Care Rationing | 1 | 2020 | 94 | 0.170 |
Why?
|
| Cardiotonic Agents | 2 | 2017 | 151 | 0.170 |
Why?
|
| Critical Pathways | 1 | 2020 | 149 | 0.170 |
Why?
|
| Professional-Family Relations | 1 | 2020 | 134 | 0.170 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 739 | 0.170 |
Why?
|
| Amyloid | 2 | 2016 | 97 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2023 | 37905 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2021 | 191 | 0.160 |
Why?
|
| Triage | 1 | 2020 | 252 | 0.160 |
Why?
|
| Point-of-Care Systems | 2 | 2015 | 196 | 0.160 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2015 | 126 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 960 | 0.160 |
Why?
|
| Lung Transplantation | 1 | 2022 | 359 | 0.160 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2018 | 71 | 0.160 |
Why?
|
| Betacoronavirus | 2 | 2020 | 527 | 0.160 |
Why?
|
| Terminal Care | 1 | 2023 | 447 | 0.160 |
Why?
|
| Resuscitation Orders | 1 | 2018 | 68 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2020 | 414 | 0.150 |
Why?
|
| Pyridones | 1 | 2020 | 348 | 0.150 |
Why?
|
| Adult | 19 | 2023 | 77950 | 0.150 |
Why?
|
| Female | 29 | 2023 | 141928 | 0.150 |
Why?
|
| Pandemics | 3 | 2022 | 1559 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2021 | 548 | 0.150 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2016 | 4 | 0.150 |
Why?
|
| Medicare | 2 | 2018 | 860 | 0.140 |
Why?
|
| Patient Preference | 1 | 2019 | 218 | 0.140 |
Why?
|
| Angiopoietin-2 | 1 | 2016 | 38 | 0.140 |
Why?
|
| Assisted Circulation | 1 | 2016 | 37 | 0.140 |
Why?
|
| Endocardium | 3 | 2018 | 50 | 0.140 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 705 | 0.140 |
Why?
|
| Mortality | 1 | 2018 | 343 | 0.140 |
Why?
|
| Cardiac Volume | 1 | 2015 | 18 | 0.140 |
Why?
|
| Atovaquone | 1 | 2015 | 8 | 0.130 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2015 | 303 | 0.130 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 651 | 0.130 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 228 | 0.130 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 715 | 0.130 |
Why?
|
| Transplant Recipients | 1 | 2017 | 324 | 0.130 |
Why?
|
| Aortic Valve | 2 | 2016 | 581 | 0.130 |
Why?
|
| Ethics, Medical | 1 | 2018 | 442 | 0.130 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 190 | 0.120 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 120 | 0.120 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2013 | 68 | 0.120 |
Why?
|
| Heart Ventricles | 2 | 2017 | 846 | 0.110 |
Why?
|
| Ultrasonography, Doppler | 1 | 2014 | 231 | 0.110 |
Why?
|
| Rabbits | 1 | 2015 | 957 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 5687 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 14889 | 0.110 |
Why?
|
| Aged | 17 | 2023 | 70117 | 0.110 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 4892 | 0.110 |
Why?
|
| Mycoses | 1 | 2016 | 386 | 0.100 |
Why?
|
| Death | 2 | 2023 | 119 | 0.100 |
Why?
|
| Amyloidosis | 1 | 2014 | 176 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 435 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 1374 | 0.100 |
Why?
|
| Glycation End Products, Advanced | 1 | 2011 | 31 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2016 | 712 | 0.100 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2011 | 21 | 0.100 |
Why?
|
| Research Design | 1 | 2019 | 1544 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 446 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2020 | 1471 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 527 | 0.100 |
Why?
|
| Ambulatory Care | 1 | 2015 | 554 | 0.100 |
Why?
|
| Hypocalcemia | 1 | 2011 | 59 | 0.100 |
Why?
|
| Prognosis | 6 | 2019 | 21713 | 0.090 |
Why?
|
| Plasma Exchange | 1 | 2011 | 117 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2010 | 97 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 1011 | 0.090 |
Why?
|
| Sarcomeres | 1 | 2009 | 42 | 0.090 |
Why?
|
| Standard of Care | 2 | 2022 | 243 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 1547 | 0.090 |
Why?
|
| Prosthesis Design | 3 | 2017 | 749 | 0.080 |
Why?
|
| Reoperation | 1 | 2013 | 1382 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 592 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 112 | 0.080 |
Why?
|
| Hospital Costs | 2 | 2021 | 228 | 0.080 |
Why?
|
| HIV Infections | 1 | 2021 | 2134 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2011 | 546 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2017 | 12873 | 0.080 |
Why?
|
| Endothelium | 1 | 2008 | 158 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2011 | 576 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 7702 | 0.080 |
Why?
|
| Thermodilution | 1 | 2007 | 15 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 172 | 0.080 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 2007 | 10 | 0.070 |
Why?
|
| Coronary Circulation | 1 | 2008 | 253 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2007 | 193 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 4744 | 0.070 |
Why?
|
| Natriuretic Agents | 1 | 2007 | 31 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 4320 | 0.070 |
Why?
|
| Equipment Design | 2 | 2016 | 1204 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2008 | 429 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2008 | 875 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2010 | 739 | 0.070 |
Why?
|
| Incidence | 4 | 2019 | 5673 | 0.070 |
Why?
|
| Perioperative Care | 1 | 2010 | 451 | 0.070 |
Why?
|
| Treatment Outcome | 8 | 2023 | 32848 | 0.070 |
Why?
|
| Resource Allocation | 2 | 2020 | 67 | 0.060 |
Why?
|
| Pacemaker, Artificial | 1 | 2007 | 213 | 0.060 |
Why?
|
| Communication | 2 | 2023 | 876 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 2007 | 221 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 6009 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 343 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 435 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2007 | 629 | 0.060 |
Why?
|
| Prolapse | 1 | 2003 | 13 | 0.060 |
Why?
|
| Survival Rate | 4 | 2019 | 12221 | 0.060 |
Why?
|
| Chicago | 1 | 2003 | 40 | 0.060 |
Why?
|
| Heart | 2 | 2022 | 1223 | 0.060 |
Why?
|
| Morals | 1 | 2024 | 70 | 0.060 |
Why?
|
| Supreme Court Decisions | 1 | 2023 | 12 | 0.060 |
Why?
|
| Mutation | 2 | 2016 | 15179 | 0.060 |
Why?
|
| Time Factors | 5 | 2017 | 12926 | 0.060 |
Why?
|
| Kidney | 2 | 2023 | 2146 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2003 | 355 | 0.050 |
Why?
|
| Physicians, Women | 1 | 2004 | 105 | 0.050 |
Why?
|
| Aortography | 1 | 2003 | 181 | 0.050 |
Why?
|
| Career Choice | 1 | 2004 | 232 | 0.050 |
Why?
|
| Comorbidity | 2 | 2021 | 2352 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 4971 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2022 | 104 | 0.050 |
Why?
|
| Patient Admission | 1 | 2003 | 220 | 0.050 |
Why?
|
| Uncertainty | 1 | 2024 | 320 | 0.050 |
Why?
|
| Social Class | 1 | 2023 | 310 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2022 | 1335 | 0.050 |
Why?
|
| Exercise Test | 2 | 2015 | 312 | 0.050 |
Why?
|
| Prevalence | 2 | 2021 | 3260 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2014 | 422 | 0.050 |
Why?
|
| Heart Atria | 1 | 2003 | 352 | 0.050 |
Why?
|
| Nursing Homes | 1 | 2021 | 99 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2003 | 672 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 485 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 4314 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 552 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2020 | 155 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2021 | 317 | 0.040 |
Why?
|
| Warfarin | 1 | 2020 | 152 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 7551 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1112 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 135 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 6295 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2022 | 708 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2003 | 732 | 0.040 |
Why?
|
| Weight Loss | 1 | 2021 | 627 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 978 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 500 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 661 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2016 | 64 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 111 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2015 | 2292 | 0.030 |
Why?
|
| Cannula | 1 | 2016 | 35 | 0.030 |
Why?
|
| Arteriovenous Malformations | 1 | 2016 | 70 | 0.030 |
Why?
|
| Thrombin | 1 | 2016 | 99 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2015 | 1863 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2015 | 62 | 0.030 |
Why?
|
| Blood Volume Determination | 1 | 2015 | 8 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 164 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 263 | 0.030 |
Why?
|
| Sex Factors | 1 | 2021 | 2139 | 0.030 |
Why?
|
| Anemia | 1 | 2021 | 689 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2018 | 598 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2015 | 194 | 0.030 |
Why?
|
| Septal Occluder Device | 1 | 2015 | 49 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 206 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 107 | 0.030 |
Why?
|
| Risk Factors | 3 | 2017 | 17523 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 671 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1900 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 6869 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 1099 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 475 | 0.030 |
Why?
|
| Ultrafiltration | 1 | 2013 | 22 | 0.030 |
Why?
|
| Exercise | 1 | 2021 | 1183 | 0.030 |
Why?
|
| Jehovah's Witnesses | 1 | 2013 | 21 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 752 | 0.030 |
Why?
|
| Image Enhancement | 2 | 2008 | 561 | 0.030 |
Why?
|
| Biomarkers | 2 | 2016 | 5047 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 787 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 665 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 531 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2010 | 11965 | 0.030 |
Why?
|
| Hypertension | 1 | 2021 | 1503 | 0.030 |
Why?
|
| Stroke | 1 | 2020 | 1144 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2021 | 6100 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 477 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2018 | 945 | 0.020 |
Why?
|
| Adolescent | 2 | 2023 | 31252 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2016 | 1048 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2015 | 1145 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 7573 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2010 | 80 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2009 | 18 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 59536 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 6682 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 128 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 323 | 0.020 |
Why?
|
| Infant | 2 | 2018 | 13310 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 4109 | 0.020 |
Why?
|
| Ethics, Clinical | 1 | 2007 | 78 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 219 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 4298 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 703 | 0.020 |
Why?
|
| Ventriculography, First-Pass | 1 | 2005 | 1 | 0.020 |
Why?
|
| Pedigree | 1 | 2009 | 1890 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 4988 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 1054 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2010 | 1234 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 2843 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 1537 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 2074 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 1819 | 0.020 |
Why?
|
| Career Mobility | 1 | 2004 | 95 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 9244 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2004 | 122 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 2055 | 0.010 |
Why?
|
| Mentors | 1 | 2004 | 203 | 0.010 |
Why?
|
| Child | 2 | 2016 | 29154 | 0.010 |
Why?
|
| Contrast Media | 1 | 2008 | 1472 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2009 | 2022 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 21445 | 0.010 |
Why?
|
| Family | 1 | 2004 | 736 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 29902 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 8223 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2004 | 1375 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2009 | 16273 | 0.010 |
Why?
|